bilirubin encephalopathy
bilirubin encephalopathy
Explore linked clinical trials. Standard reference: MONDO:00184772 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns | Brain Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hyperbilirubinemia, Neonatal, Infant, Newborn, Diseases, Jaundice, Neonatal, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bilirubin encephalopathy, brain disorder, central nervous system disorder, fetal erythroblastosis, hematologic disorder, hyperbilirubinemia, immune system disorder, metabolic disease, nervous system disorder | Not yet recruiting | Not stated | 2026-01-02 | NCT07315126 | |
| Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration | Brain Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Nutritional and Metabolic Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, bilirubin encephalopathy, brain disorder, central nervous system disorder, fetal erythroblastosis, hematologic disorder, hyperbilirubinemia, immune system disorder, metabolic disease, nervous system disorder, pregnancy disorder | Active, not recruiting | Phase 2 | 2025-11-28 | NCT04584983 |